CALTON & ASSOCIATES, INC. - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 258 filers reported holding ACCELERON PHARMA INC in Q4 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.4%.

Quarter-by-quarter ownership
CALTON & ASSOCIATES, INC. ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q3 2021$370,000
+36.0%
2,151
-0.8%
0.08%
+55.8%
Q2 2021$272,000
-10.5%
2,168
-3.2%
0.05%
-11.9%
Q1 2021$304,000
+16.0%
2,239
+9.2%
0.06%
+25.5%
Q4 2020$262,000
+9.2%
2,050
-3.8%
0.05%
-4.1%
Q3 2020$240,0002,1310.05%
Other shareholders
ACCELERON PHARMA INC shareholders Q4 2020
NameSharesValueWeighting ↓
Polaris Venture Management Co IV LLC 1,480,060$53,563,00085.86%
NEXTHERA CAPITAL LP 217,817$7,883,0004.84%
Novo Holdings A/S 903,833$32,710,0002.90%
SECTORAL ASSET MANAGEMENT INC 481,765$17,435,0001.71%
Perceptive Advisors 589,890$21,348,0001.38%
RA Capital Management 318,565$11,529,0001.19%
OAK RIDGE INVESTMENTS LLC 1,226,468$44,386,0001.15%
Granahan Investment Management 817,149$29,573,0000.97%
Eventide Asset Management 428,900$15,522,0000.95%
QVT Financial LP 636,764$23,044,0000.87%
View complete list of ACCELERON PHARMA INC shareholders